ArticleContemporary clinical trials communications2022

Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol.

Takahiro Higashibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.